Xenon Pharmaceuticals
Erin MacKenzie is a Clinical Scientist 3 at Xenon Pharmaceuticals Inc. since September 2023, following over a decade at Lundbeck, where roles included Senior Scientific Advisor, CNS, Scientific Advisor, CNS, and Medical Science Liaison, CNS. Prior to Lundbeck, Erin served as a Postdoctoral Fellow at the University of Alberta and managed clinical development at Afexa Life Sciences. Educational qualifications include a PhD in Psychiatry from the University of Alberta and a BSc in Biopsychology from The University of British Columbia.
This person is not in the org chart
Xenon Pharmaceuticals
1 followers
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders.